Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limitedverified

SPARC.NS

Price:

$146.09

Market Cap:

$47.41B

Sun Pharma Advanced Research Company Limited, a biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops new chemical and biological entities, and reformulated products with a therapeutic focus on oncology, neurodegeneration, ophthalmology, and dermatology. The company offers Elepsia, a formulation of levetiracetam that is an anti-epileptic agent to treat epilepsy disorder; and Xelpros, a latanoprost ophthalmic emulsion for the treatment of open-angle glaucoma or ocular hypertension. In addition, it is developing SDN-037, a formulation of difluprednate for the treatment of inflammation and pain associated with ocu...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2003-01-14

Stock Exchange

NSE

Ticker

SPARC.NS

The Enterprise Value as of December 2025 (TTM) for Sun Pharma Advanced Research Company Limited (SPARC.NS) is 51.57B

According to Sun Pharma Advanced Research Company Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 51.57B. This represents a change of -3.64% compared to the average of 53.51B of the last 4 quarters.

Sun Pharma Advanced Research Company Limited (SPARC.NS) Historical Enterprise Value (quarterly & annually)

How has SPARC.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Sun Pharma Advanced Research Company Limited over the last ten years is 65.98B. The current 51.57B Enterprise Value has changed 7.72% with respect to the historical average. Over the past ten years (40 quarters), SPARC.NS's Enterprise Value was at its highest in in the December 2017 quarter at 124.85B. The Enterprise Value was at its lowest in in the March 2020 quarter at 25.92B.

Quarterly (TTM)
Annual

Average

65.98B

Median

59.83B

Minimum

25.95B

Maximum

123.65B

Sun Pharma Advanced Research Company Limited (SPARC.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sun Pharma Advanced Research Company Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 141.45%

Maximum Annual Enterprise Value = 123.65B

Minimum Annual Increase = -59.43%

Minimum Annual Enterprise Value = 25.95B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202550.16B-59.43%
2024123.65B141.45%
202351.21B-35.11%
202278.92B99.69%
202139.52B52.27%
202025.95B-47.64%
201949.57B-47.83%
201895.02B22.94%
201777.30B12.93%
201668.45B-40.78%

Sun Pharma Advanced Research Company Limited (SPARC.NS) Average Enterprise Value

How has SPARC.NS Enterprise Value performed in the past?

The current Enterprise Value of Sun Pharma Advanced Research Company Limited (SPARC.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

75.01B

5-year avg

68.69B

10-year avg

65.98B

Sun Pharma Advanced Research Company Limited (SPARC.NS) Enterprise Value vs. Peers

How is SPARC.NS’s Enterprise Value compared to its peers?

Sun Pharma Advanced Research Company Limited’s Enterprise Value is greater than Suven Life Sciences Limited (36.65B), greater than Suven Life Sciences Limited (36.65B), greater than Aarti Drugs Limited (41.87B), greater than Aarti Drugs Limited (41.87B), greater than RPG Life Sciences Limited (35.31B), greater than RPG Life Sciences Limited (35.31B), greater than Innova Captab Limited (41.61B), greater than Orchid Pharma Limited (45.45B), greater than Gufic Biosciences Limited (34.77B), greater than Gufic Biosciences Limited (34.77B),

Build a custom stock screener for Sun Pharma Advanced Research Company Limited (SPARC.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sun Pharma Advanced Research Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sun Pharma Advanced Research Company Limited (SPARC.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sun Pharma Advanced Research Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Sun Pharma Advanced Research Company Limited's Enterprise Value?

What is the highest Enterprise Value for Sun Pharma Advanced Research Company Limited (SPARC.NS)?

What is the 3-year average Enterprise Value for Sun Pharma Advanced Research Company Limited (SPARC.NS)?

What is the 5-year average Enterprise Value for Sun Pharma Advanced Research Company Limited (SPARC.NS)?

How does the current Enterprise Value for Sun Pharma Advanced Research Company Limited (SPARC.NS) compare to its historical average?